To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

Sukhbir Singh appointed Member (Electrical), Railway Board

New Delhi, Apr 10 (UNI) Mr Sukhbir Singh has taken over as the Member (Electrical), Railway Board, New Delhi and ex-officio Secretary to the Government of India.

Prior to his new assignment, he was General Manager, North Eastern Railway.

Born in 1949, Mr Singh, who assumed the charge of current post on April 8, is a gold medalist in Bachelor in Engineering (electrical) from University of Roorkee (now IIT, Roorkee).

An officer of the 1971 batch of the Indian Railway Service of Electrical Engineering (IRSEE), he worked in various capacities, including General Manager, Chittaranjan Locomotive Works; Chief Electrical Engineer, -Western Railway; Divisional Railway Manager, Allahabad; Chief Electrical Engineer (Loco), Central Railway; and Chief Electrical Engineer (Suburban service, Projects), Western Railway, Mumbai.

He also served a stint as Additional Divisional Railway Manager, Central Railway, Nagpur and Additional Divisional Railway Manager, Mumbai.

Mr Singh was awarded Electrical Shield, 2006 for best performance of the electrical assets of Western Railway.

During his tenure as General Manager, North Eastern Railway, two world records were set up: completion of 108-metre-long Foot Over Bridge (FOB) at Chhapra (Bihar) within two months and innovative single block method for execution of a major traffic facility p, also at Chhapra.

He underwent a course in Strategic Management at the University of Manchester, UK and also attended the Advance Leadership Programme at Stern Business School, New York.

UNI SKS LS DS1417

Small molecule drug may help treat hormone-accelerated breast cancer

Washington, January 29 (ANI): University of Missouri scientists in the United States say that a small molecule drug has the potential as a novel chemotherapeutic treatment for breast cancer accelerated by the hormone progestin.The researchers have revealed that the drug called PRIMA-1 targets the most common mutated gene, p53, in human cancer cells."We demonstrated that PRIMA-1 was an effective drug to treat and prevent emergence of progestin-accelerated mammary tumors in rats," said Salman Hyder, professor of biomedical sciences.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login